Cross-fund · 5 holders
SNDX
SYNDAX PHARMACEUTICALS INC
CUSIP 87164F105
5
Tracked holders
$392.7M
Aggregate value
17,437,373
Shares
5
Active funds
Funds holding SNDX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $192.8M | — | +15,424 | +0.2% |
| Vanguard | Institutional | Q4 2025 | $130.9M | — | +1,091,717 | +21.2% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $46.4M | 0.06% | -2,896,506 | -59.3% |
| Citadel | Multi-Strategy | Q1 2026 | $17.9M | — | +399,239 | +108.4% |
| Millennium | Multi-Strategy | Q1 2026 | $4.7M | — | +97,587 | +95.7% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.